Other Clinical Trial - Quantitative Analysis of EEG Changes in Response to

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study will quantify the nociception using Analgesia Nociception Index (ANI) during general anesthesia and analyze the differences in EEG depending on the degree of nociception. Additionally, the investigators will quantify the nociception during recovery and analyze the differences in EEG depending on the degree of nociception.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03210636` - Looking at Safety and Feasibility of Novel Laparoscopic Device (LapSpace)	N/A
	Not yet recruiting	`NCT03371953` - Evaluation of Atracurium-vecuronium Combination in Laparosocpic Surgery	Phase 4

NCT number	NCT06342570
Study type	Observational
Source	Gangnam Severance Hospital
Contact	Myung Il Bae
Phone	82-2-2019-6611
Email	BMI87@yuhs.ac
Status	Recruiting
Phase
Start date	April 21, 2024
Completion date	December 30, 2026

Quantitative Analysis of EEG Changes in Response to Nociception

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms